MarketCap
Innate Pharma S.A. IPHA
€ 1.32
-6.96%
Facebook
X
Telegram
Innate Pharma S.A. Current Ratio | IPHA
Current Ratio Jährlich Innate Pharma S.A.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 2.03 | 2.18 | 1.59 | 1.51 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.18 | 1.51 | 1.83 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Axsome Therapeutics
AXSM
|
1.15 | $ 143.88 | -0.8 % | $ 7.16 B |  USA |
 |
Heat Biologics, Inc.
HTBX
|
31.1 | - | -5.76 % | $ 99.8 M | USA |
 |
Kindred Biosciences, Inc.
KIN
|
9.08 | - | 0.11 % | $ 419 M | USA |
 |
BioNTech SE
BNTX
|
7.95 | $ 86.9 | -1.38 % | $ 21 B |  Germany |
 |
Alterity Therapeutics Limited
ATHE
|
12.7 | $ 2.1 | 0.48 % | $ 13.4 B |  Australia |
 |
Shineco, Inc.
TYHT
|
5.25 | - | -3.90 % | $ 97.2 M |  China |
 |
Actinium Pharmaceuticals
ATNM
|
1.18 | $ 1.41 | -7.24 % | $ 44 M | USA |
 |
Millendo Therapeutics, Inc.
MLND
|
5.12 | - | -5.36 % | $ 20.2 M | USA |
 |
Aytu BioScience
AYTU
|
1.41 | $ 1.93 | 1.58 % | $ 23.8 M | USA |
 |
Codexis
CDXS
|
1.52 | $ 1.29 | 0.39 % | $ 112 M | USA |
 |
Intec Pharma Ltd
NTEC
|
2.81 | - | -12.45 % | $ 17.7 M |  Israel |
 |
Genmab A/S
GMAB
|
5.03 | $ 44.64 | 1.94 % | $ 2.89 B |  Danmark |
 |
GeoVax Labs
GOVX
|
2.52 | $ 0.19 | -7.18 % | $ 182 K | USA |
 |
Cellectar Biosciences
CLRB
|
2.96 | $ 1.23 | 0.82 % | $ 3.21 M | USA |
 |
Galectin Therapeutics
GALT
|
0.134 | $ 3.19 | -0.31 % | $ 204 M | USA |
 |
GT Biopharma
GTBP
|
6.14 | $ 5.17 | -5.31 % | $ 28.5 M | USA |
 |
Progenity, Inc.
PROG
|
1.74 | - | -3.47 % | $ 164 M | USA |
 |
Genprex
GNPX
|
4.62 | $ 1.81 | 0.22 % | $ 1.69 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
4.37 | - | 1.52 % | $ 136 M | USA |
 |
Cue Biopharma
CUE
|
2.68 | $ 18.45 | -1.1 % | $ 1.75 B | USA |
 |
Seneca Biopharma, Inc.
SNCA
|
4.02 | - | -1.19 % | $ 28.7 M | USA |
 |
DiaMedica Therapeutics
DMAC
|
13.8 | $ 8.74 | 0.23 % | $ 411 M | USA |
 |
Cardiff Oncology
CRDF
|
3.75 | $ 0.81 | -10.82 % | $ 54.1 M | USA |
 |
Inhibrx
INBX
|
1.16 | $ 88.26 | -5.48 % | $ 4.16 B | USA |
 |
Kazia Therapeutics Limited
KZIA
|
0.422 | $ 7.91 | 1.28 % | $ 121 M | Australia |
 |
Fate Therapeutics
FATE
|
8.17 | $ 2.06 | -2.61 % | $ 245 M | USA |
 |
Eton Pharmaceuticals
ETON
|
1.4 | $ 50.15 | 0.3 % | $ 1.35 B | USA |
 |
Fulcrum Therapeutics
FULC
|
21.2 | $ 3.65 | -0.95 % | $ 231 M | USA |
 |
Hutchison China MediTech Limited
HCM
|
3.49 | $ 14.31 | -0.38 % | $ 12.3 B | China |
 |
IDEAYA Biosciences
IDYA
|
12.8 | $ 33.2 | -4.35 % | $ 2.94 B | USA |
 |
InflaRx N.V.
IFRX
|
4.04 | $ 1.57 | 0.32 % | $ 106 M | Germany |
 |
Immutep Limited
IMMP
|
11.8 | $ 3.07 | -4.06 % | $ 4.47 B | Australia |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
1.46 | $ 1.89 | -6.44 % | $ 1.27 B | Israel |
 |
Zoetis
ZTS
|
1.27 | $ 80.89 | -0.17 % | $ 35.9 B | USA |
 |
Kala Pharmaceuticals
KALA
|
3.81 | $ 0.19 | -1.95 % | $ 1.55 M | USA |
 |
Mereo BioPharma Group plc
MREO
|
3.36 | $ 0.28 | -1.99 % | $ 223 M |  Britain |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
3.9 | $ 73.0 | -4.87 % | $ 5.42 B | USA |
 |
Karyopharm Therapeutics
KPTI
|
0.27 | $ 0.48 | -6.34 % | $ 5.25 K | USA |
 |
MediciNova
MNOV
|
11.4 | $ 1.41 | 1.44 % | $ 69.2 M | USA |
 |
Seres Therapeutics
MCRB
|
1.47 | $ 2.01 | -3.83 % | $ 17.8 M | USA |
 |
MediWound Ltd.
MDWD
|
3.17 | $ 12.1 | 0.83 % | $ 329 M | Israel |
 |
SELLAS Life Sciences Group
SLS
|
10.5 | $ 11.35 | -1.69 % | $ 1.24 B | USA |
 |
Precigen
PGEN
|
1.16 | $ 6.05 | -2.34 % | $ 1.89 B | USA |
 |
PolyPid Ltd.
PYPD
|
24.7 | $ 5.3 | 0.95 % | $ 86.7 M | Israel |
 |
Rocket Pharmaceuticals
RCKT
|
6.21 | $ 2.27 | -0.87 % | $ 252 M | USA |
 |
Avidity Biosciences
RNA
|
7.27 | $ 8.04 | -1.93 % | $ 1.11 B | USA |
 |
Summit Therapeutics
SMMT
|
8.14 | $ 14.5 | -6.3 % | $ 10.8 B | Britain |
 |
Celsion Corporation
CLSN
|
2.35 | - | -6.63 % | $ 13.9 M | USA |
 |
I-Mab
IMAB
|
2.92 | - | - | $ 866 M | China |